42 related articles for article (PubMed ID: 38507057)
1. The dual role of autophagy in acute myeloid leukemia.
Seo W; Silwal P; Song IC; Jo EK
J Hematol Oncol; 2022 May; 15(1):51. PubMed ID: 35526025
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer analysis of DDIT4 identifying its prognostic value and function in acute myeloid leukemia.
Li F; Miao J; Liu R; Zhang R; He A
J Cancer Res Clin Oncol; 2024 Mar; 150(3):144. PubMed ID: 38507057
[TBL] [Abstract][Full Text] [Related]
3. Pan-cancer analysis of oncogenic TNFAIP2 identifying its prognostic value and immunological function in acute myeloid leukemia.
Lin MS; Zhong HY; Yim RL; Chen QY; Du HL; He HQ; Lin K; Zhao P; Gao R; Gao F; Zhang MY
BMC Cancer; 2022 Oct; 22(1):1068. PubMed ID: 36243694
[TBL] [Abstract][Full Text] [Related]
4. Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancer.
Chen X; Li Z; Liang M; Zhang Z; Zhu D; Lin B; Zhou R; Lu Y
World J Surg Oncol; 2023 Jun; 21(1):194. PubMed ID: 37391802
[TBL] [Abstract][Full Text] [Related]
5. High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia.
Li K; Chen L; Zhang H; Wang L; Sha K; Du X; Li D; Zheng Z; Pei R; Lu Y; Tong H
Aging (Albany NY); 2021 Apr; 13(8):11988-12006. PubMed ID: 33891561
[TBL] [Abstract][Full Text] [Related]
6. DDIT4 promotes gastric cancer proliferation and tumorigenesis through the p53 and MAPK pathways.
Du F; Sun L; Chu Y; Li T; Lei C; Wang X; Jiang M; Min Y; Lu Y; Zhao X; Nie Y; Fan D
Cancer Commun (Lond); 2018 Jul; 38(1):45. PubMed ID: 29976242
[TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management.
Shimony S; Stahl M; Stone RM
Am J Hematol; 2023 Mar; 98(3):502-526. PubMed ID: 36594187
[TBL] [Abstract][Full Text] [Related]
8. Role of Biomarkers in the Management of Acute Myeloid Leukemia.
Small S; Oh TS; Platanias LC
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498870
[TBL] [Abstract][Full Text] [Related]
9. Acute Myeloid Leukemia: Historical Perspective and Progress in Research and Therapy Over 5 Decades.
Kantarjian HM; Short NJ; Fathi AT; Marcucci G; Ravandi F; Tallman M; Wang ES; Wei AH
Clin Lymphoma Myeloma Leuk; 2021 Sep; 21(9):580-597. PubMed ID: 34176779
[TBL] [Abstract][Full Text] [Related]
10. Maintenance Therapy in AML.
Reville PK; Kadia TM
Front Oncol; 2020; 10():619085. PubMed ID: 33604298
[TBL] [Abstract][Full Text] [Related]
11. Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development.
Stanchina M; Soong D; Zheng-Lin B; Watts JM; Taylor J
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33139625
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of DDIT4 predicts poor prognosis in acute myeloid leukaemia.
Cheng Z; Dai Y; Pang Y; Jiao Y; Liu Y; Cui L; Quan L; Qian T; Zeng T; Si C; Huang W; Chen J; Pang Y; Ye X; Shi J; Fu L
J Cell Mol Med; 2020 Jan; 24(1):1067-1075. PubMed ID: 31755224
[TBL] [Abstract][Full Text] [Related]
13. The multi-factorial nature of clinical multidrug resistance in cancer.
Assaraf YG; Brozovic A; Gonçalves AC; Jurkovicova D; Linē A; Machuqueiro M; Saponara S; Sarmento-Ribeiro AB; Xavier CPR; Vasconcelos MH
Drug Resist Updat; 2019 Sep; 46():100645. PubMed ID: 31585396
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
